You are here

  1. Home
  2. Innovation & Inequality: Speakers

Innovation & Inequality: Speakers

Back to the workshop website

Mariana Mazzucato

Mariana Mazzucato

Mariana Mazzucato is a Professor of Economics at the Open University (UK). After receiving her PhD in 1999 from the New School University, she became Assistant Professor of Economics at the University of Denver, and then joined the London Business School through a Marie Curie Post-Doctoral Fellowship. She is currently the Coordinator of a 3 year FP7 project on Finance, Innovation and Growth (FINNOV, 2009-2012, EC Contribution Euros 1.5 million) and is Economics Director of the ESRC Innogen centre. Since 2006 she has been a Visiting Professor at the Bocconi University (KITES centre). She is Deputy Director of the Open University's Innovation, Knowledge and Development (IKD) inter-faculty research centre which she directed from 2004-2009.

PDF  Presentation: Innovation and Inequality: the need for new indicators from Pharma and beyond (PDF document, 990 KB)

Luigi Orsenigo

Luigi Orsenigo is Professor of Industrial Organization at the University of Brescia, Italy. He is also Fellow of KITeS, Bocconi University, Milan, Italy and co-Investigator at Innogen. After receiving his Ph.D from the Science Policy Research Unit, University of Sussex in 1989, he has been affiliated with Bocconi University, the University of Brescia and Open University. His work concerns mainly the economics of innovation, industrial dynamics and the bio-pharmaceutical industry.  He has published various books and  several articles on major international journals. He is Editor of the Journal of Evolutionary Economics. He has been advising several Italian and international institutions on matters of innovation and industrial policy.

Carlota Perez

Carlota Perez works as an independent consultant and lecturer with several part-time university affiliations. She is Visiting Research Associate, CFAP/CERF, Judge Business School and Visiting Scholar in the Faculty of Economics, both in Cambridge University, UK; Professor of Technology and Development, Technological University of Tallinn, Estonia and Honorary Research Fellow, SPRU, University of Sussex, UK. She is advisor to governments of developed and developing countries, international organisations and global corporations (IBM, Cisco, Ericsson and others). Her book Technological Revolutions and Financial Capital: the Dynamics of Bubbles and Golden Ages has contributed to the current understanding of the relationship between finance and technology and between them and institutional change.

PDF  Abstract: The diffusion of technological revolutions and income distribution (PDF document, 11 KB)

Benjamin Coriat

Benjamin Coriat is Professor of Economics at the University Paris 13. His research domains includes: IPR Sytems,  Industrial Economics, Economics of Innovation and Technical change.He is presently Chairman of the Coordinated Action "Economics of Aids and Access to HIV/Care in Developing Countries" at ANRS (National French Agency for Research on Aids). He has extensively published on the issue of IPR and Health. Last book  : B. Coriat (ed) "The political economy of HIV/AIDS in developing countries. TRIPS, Public Health Systems and Free Access", Edward Elgar, 2008.

PDF  Abstract: How TRIPS are building enhanced inequalities in access to care: the case of HIV/AIDS drugs (PDF document, 16 KB)
PDF  Presentation: How TRIPS are building enhanced inequalities in access to care: the case of HIV/AIDS drugs (PDF document, 330 KB)

Fabienne Orsi

Fabienne Orsi is economist and researcher at IRD (Institute of Research for Development), currently affiliated with the SE4S research Unit (IRD/INSERM/University of Aix-Marseille II) in Marseilles, France. She began her research career working on the evolution of patentability in the field of human genome research and its co-evolution with financial market rules. Her current research focuses on intellectual property rights in the field of pharmaceuticals, economics of innovation, and access to drugs in developing countries. Recently, she has carried out research on new kinds of "commons" for drugs discovery and development.

PDF  Abstract: How TRIPS are building enhanced inequalities in access to care: the case of HIV/AIDS drugs (PDF document, 16 KB)
PDF  Presentation: How TRIPS are building enhanced inequalities in access to care: the case of HIV/AIDS drugs (PDF document, 330 KB)

Theo Papaioannou

Theo Papaioannou

Theo Papaioannou is a Lecturer in Innovation and Politics of Development at the ESRC Centre for Social and Economic Research on Innovation in Genomics (INNOGEN) and the Development Policy and Practice Group (DPP) at the Open University. He is also leading the Governance of Innovation and Development Research Stream at the IKD Centre at The Open University. Theo has researched and published extensively in the areas of innovation, politics and justice. His recent publications include: (with Lyall, C. and Smith, J.) The Limits to Governance: The Challenge of Policy-Making for the New Life Sciences, Aldershot: Ashgate (2009); 'The Impact of New Life Sciences Innovation on Political Theories of Justice' Genomics, Society and Policy (2009); (with Yanacopulos, H. and Aksoy, Z.) 'Global Justice: From Theory to Development Action' Journal of International Development, (2009).

PDF  Abstract: Technological Innovation, Global Justice and Politics of Development (PDF document, 16 KB)
PDF  Presentation: Technological Innovation, Global Justice and Politics of Development (PDF document, 220 KB)

Keren Bright

Keren Bright

Keren Bright is Director of the Law Programme (undergraduate) at The Open University and a Senior Lecturer in Law. Keren also has a consultancy with the UK Centre for Legal Education at Warwick University, which is the law subject centre of the Higher Education Academy. The consultancy has encompassed the professional development of law lecturers and writing resources for the UKCLE website.

Keren qualified as a solicitor in 1998 in a practice specialising in media law and then taught Business Law at the Oxford Institute of Legal Practice, where she was principal lecturer in law.

As regards Keren's research and scholarship interests, she is currently researching the interface between intellectual property, human rights and corporate social responsibility, with particular reference to the pharmaceutical industry.

PDF  Abstract: Access to medicines: intellectual property rights, human rights and justice (PDF document, 25 KB)
PDF  Presentation: Access to medicines: intellectual property rights, human rights and justice (PDF document, 4.8 MB)

Lois Muraguri

Lois Muraguri

Lois Muraguri is a Research Fellow at INNOGEN, the ESRC Centre for Social and Economic Research on Innovation in Genomics. She was previously a doctoral candidate and Research Assistant at the Queen Mary Intellectual Property Research Institute, University of London. Lois's academic background is in law. Her research interests include intellectual property rights and their interface with health and agricultural innovation, public-private partnerships in innovation, the innovation process, technology transfer, biodiversity and access to plant genetic resources, the relationship between plant variety protection and patent law, and the international politics of intellectual property rights. Lois has worked as a consultant for inter alia, the Seed Traders Association of Kenya (STAK) and the International Crop Research Institute for Semi Arid Tropics (ICRISAT).

PDF  Abstract: Access to medicines: intellectual property rights, human rights and justice (PDF document, 25 KB)
PDF  Presentation: Access to medicines: intellectual property rights, human rights and justice (PDF document, 4.8 MB)

Maureen Mackintosh

Maureen Mackintosh is a development economist specialising in research on the operation of markets in 'social' goods, notably health, medicines and social care, in Africa and internationally.  Recent research includes an ESRC-funded project on 'Non-governmental action to improve access by the poor to good quality essential medicines', a collaborative project with Tanzanian, Indian and European researchers; and a UK NHS-funded project on 'The Professional experience of governance and incentives in the National Health Service' looking particularly at long term complex conditions and mental health. Her most recent publications include Mackintosh M., Chataway, J. and Wuyts M. (eds.) (2008) Promoting Innovation, Productivity and Industrial Growth and Reducing Poverty: Bridging the Policy Gap Routledge, London; and Tibandebage P. and Mackintosh M. (2009) 'Maternal mortality in Africa: a gendered lens on health system failure' Socialist Register 2009.

PDF  Abstract: Essential medicines supply chains and inequality (PDF document, 18 KB)
PDF  Presentation: Essential medicines supply chains and inequality (PDF document, 220 KB)

Sebastião Loureiro

Sebastião Loureiro was born in Bahia, Brazil where he attended the Medical School at University of Bahia, graduated in 1964 and spent two years in a residence program in Preventive Medicine at University of Sao Paulo. Upon returning to Bahia he works on the development of a joint program of University of Bahia and Kellogg Foundation to strengthening teaching and investigation in Preventive Medicine in poor neighborhoods in Salvador. This experience led to the perception of the need to further his studies in epidemiology, and public health that was carried out at LSHTM, University of London.
In 1970 he was admitted to the University of Bahia as research assistant and works in the development of the Department of Preventive Medicine of the Medical School at University of Bahia and the Master in Community Health Program.
In 1978 Sebastiao Loureiro completed his studies towards a Ph.D. degree from the University of Texas with a major in Epidemiology and promoted to Associate Professor at UFBA where he carried out research on epidemiology of infectious disease and health system and policy. He also participates in the institutional and academic structuring of the Instituto de Saude Coletiva and since the year 2001the Program of Economics, Innovation and Health Technology at University of Bahia.
Recently the University of Bahia awarded him the title of Emeritus Professor and appointed him as Vice Coordinator of the Project to structure the National Institute of Health Science Innovation and Technology, an initiative of the Ministry of Science and Technology to strengthening this area.

PDF  Abstract: Diffusion of new drugs: a review on the available empirical evidence focused on developing countries (PDF document, 13 KB)
PDF  Presentation: Diffusion of new drugs: a review on the available empirical evidence focused on developing countries (PDF document, 180 KB)

Philippe Gorry

Philippe Gorry

Philippe Gorry, MD-PhD, Associate Professor at the Medical School, past-funding & executive director of university technology transfer office, is Vice-Dean for technology transfer, and administrator of the university incubator. Trained in medical genetic, his research field was on cancer-prone rare diseases & he filed several patents on transgenic mice. He worked as an expert on patenting and licensing in genetic testing for international organizations. At the present time, he is Vice-President for International Affairs at the association of french university technology managers, "Réseau C.U.R.I.E.", as well as board member of the Licensing Executive Society – France. Recently, he joined the laboratory of economics GRETha where he undertook a research project on orphan drug market and has specific interest on patent mapping & IP assets valuation.

PDF  Abstract: The political construction of orphan drugs market: between innovation and access to care (PDF document, 20 KB)
PDF  Presentation: The political construction of orphan drugs market: between innovation and access to care (PDF document, 770 KB)

Matthieu Montalban

Matthieu Montalban

Matthieu Montalban is associate professor at Université Montesquieu Bordeaux IV. He works on financialization of industries, through the role of institutional investors, private equity and corporate governance on the strategy and business models of firms, and on the social construction of markets, especially pharmaceutical and biotechnology industry, by using institutionalist and regulationist approach. He published several articles and book chapters on this question. Montalban Matthieu and Leaver Adam (2009), "Sanofi-Aventis and the Complexity of Capitalist Organization", Competition and Change. Vol. 14 No. 1, March, 2010, 1–22. Montalban Matthieu (2008), "Shareholder value, political work and globalization in the pharmaceutical industry", in Jullien B. and Smith A., Industries and Globalization: The Political Causality of Divergent Responses, Palgrave, Basingstoke.

PDF  Abstract: The political construction of orphan drugs market: between innovation and access to care (PDF document, 20 KB)
PDF  Presentation: The political construction of orphan drugs market: between innovation and access to care (PDF document, 770 KB)

William Lazonick

William Lazonick

William Lazonick is Professor in the Department of Regional Economic and Social Development at University of Massachusetts Lowell and Director of the UMass Lowell Center for Industrial Competitiveness. He is also affiliated with the CNRS Groupe de Recherche en Économie Théorique et Appliquée, Université Montesquieu Bordeaux IV, where he is engaged in collaborative research on finance, innovation, and growth, funded primarily by the European Commission. He is directing a new international project on financial institutions for innovation and development, funded by the Ford Foundation, with a focus on the United States, Japan, and China. He is also collaborating on research projects based in Britain, France, Germany, Ireland, Sweden, and the United States.

PDF  Abstract: Do financial markets support innovation or inequity in the biotech drug development process? (PDF document, 20 KB)
PDF  Paper: Do financial markets support innovation or inequity in the biotech drug development process? (PDF document, 710 KB)
PDF  Presentation: Do financial markets support innovation or inequity in the biotech drug development process? (PDF document, 420 KB)

PDF  Abstract: Why executive pay matters to innovation and inequality (PDF document, 16 KB)
PDF  Paper: Why executive pay matters to innovation and inequality (PDF document, 180 KB)
PDF  Presentation: Why executive pay matters to innovation and inequality (PDF document, 500 KB)

Mustafa Erdem Sakinç

Mustafa Erdem Sakinç

Mustafa Erdem Sakinç is a research associate at University of Bordeaux IV in the Finance, Innovation & Growth project funded by Seventh Framework Programme of European Commission. He earned a B.S. degree in economics in 2004 from Middle East Technical University (METU). He then worked for three years as a risk management specialist for a leading insurance company in Istanbul, Turkey. During this period he also did his first master's degree at the Department of Science and Technology Policy Studies in METU. Subsequently, he did a second master's degree at the Department of Regional Economic and Social Development Program at UMass Lowell, writing a thesis on agricultural cooperatives in Turkey, completed in 2009.

PDF  Abstract: Do financial markets support innovation or inequity in the biotech drug development process? (PDF document, 20 KB)
PDF  Paper: Do financial markets support innovation or inequity in the biotech drug development process? (PDF document, 710 KB)
PDF  Presentation: Do financial markets support innovation or inequity in the biotech drug development process? (PDF document, 420 KB)

Andrés Cárdenas

Andrés Cárdenas O´Farrill (Havana, Cuba 1974). Cuban economics graduate (Havana, Cuba 1997; Leipzig, Germany 2007). Since 2002 resides permanently in Germany. He has worked as planning specialist for the Cuban Ministry for Economy and Planning; and has collaborated as researcher with the Germany-based Society for Ecological Technology and System Analysis (2001, in German: Gesellschaft für ökologische Technologie und Systemanalyse e.V). Since the year 2007 is a research fellow in the Institute for Institutional and Innovations Economics at the University of Bremen in Germany. His line of investigation focuses on the role of the state in both the technological upgrading and the economic development. His current research specifically concentrates on the development of the Cuban biotechnology Industry within the context of the socialist-oriented Cuban developing economy.

PDF  Abstract: The Cuban Biotechnology Industry: An analytical framework (PDF document, 19 KB)
PDF  Paper: The Cuban Biotechnology Industry: Innovation and universal health care (PDF document, 560 KB)
PDF  Presentation: The Cuban Biotechnology Industry: Innovation and universal health care (PDF document, 1.1 MB)

Mary O'Sullivan

Mary O'Sullivan

Mary O'Sullivan is an Associate Professor of Management in the Wharton School of the University of Pennsylvania. Her research is on comparative systems of capitalism, with a particular focus on corporate governance and financial systems. She has written many articles on the subject and a book entitled Contests for Corporate Control: Corporate Governance and Economic Performance in the United States and Germany which was published by Oxford University Press in 2000. She is currently working on another book, tentatively entitled Financial Systems and Economic Change, which analyses the evolving relationship between financial markets and enterprise and industrial dynamics. O'Sullivan completed her undergraduate education at University College Dublin (B. Comm.) and then worked at McKinsey in London for a couple of years. She went from there to do an MBA at Harvard Business School and then a PhD in Business Economics at Harvard University. Prior to moving to Wharton in the summer of 2005, she was employed as an Associate Professor in the Department of Strategy at INSEAD where she had worked since January 1997. O'Sullivan developed and taught the elective on "Innovation, Strategy, and Corporate Governance" at INSEAD in 1997, 1998, 1999, 2000 and 2001.

PDF  Article: What Opportunity Is Knocking? Regulating Corporate Governance in the United States (PDF document, 180 KB)

Giovanni Dosi

Giovanni Dosi is Professor of Economics at the Sant'Anna School of Advanced Studies in Pisa where he also coordinates the Laboratory of Economics and Management (LEM) and the International Doctoral Program in Economics. His major research areas include economics of innovation and technological change, industrial organization and industrial dynamics, theory of the firm and corporate governance, economic growth and development. Professor Dosi is Co-Director of the task forces on Industrial Policy and on Intellectual Property Rights at the Initiative for Policy Dialogue, Columbia University, New York; Continental European Editor of Industrial and Corporate Change, and an Honorary Research Professor at the University of Sussex. He has co-edited Technical Change and Economic Theory (1988) and The Nature and Dynamics of Organizational Capabilities (2000). Several of his best known articles are republished in his collected essays Innovation, Organization and Economic Dynamics (2000).

PDF  Background paper: How much should society fuel the greed of innovators? (PDF document, 270 KB)

Back to the workshop website

Contact us

To find out more about our work, or to discuss a potential project, please contact:

International Development Research Office
Faculty of Arts and Social Sciences
The Open University
Walton Hall
Milton Keynes
MK7 6AA
United Kingdom

T: +44 (0)1908 858502
E: international-development-research@open.ac.uk